Loneliness and Mental Wellbeing in People With Inherited Macular Disease [0.03%]
遗传性黄斑病患者的孤独感和心理健康状况
Michael D Crossland,Marc S Tibber,Lottie A G Wood et al.
Michael D Crossland et al.
Purpose: People with vision impairment have lower mental wellbeing than those without eye disease. Loneliness is thought to be associated with lower wellbeing in this population, but the confounding effect of mental ill-h...
Nasotemporal Asymmetry in Ocular Biometry as a Biomarker for Myopia Progression in Chinese Children [0.03%]
中国人儿童鼻梁温度不对称作为近视进展的生物标志物在眼部生物测量中的作用
Tianli Peng,Li Zhang,Wenjun Xu et al.
Tianli Peng et al.
Purpose: This multicentre longitudinal study investigated nasotemporal retinal asymmetry as a geometric biomarker for monitoring myopia risk in children. ...
The Efficacy of Oral Vitamin Supplementation in Dry Eye Disease: A Systematic Review [0.03%]
口服维生素补充治疗干眼病的疗效：系统评价
Hamidreza Heidari,Maria Markoulli,Jayashree Arcot et al.
Hamidreza Heidari et al.
Introduction: Vitamins are micronutrients with a wide range of anti-inflammatory, immunomodulatory, regulatory and antioxidant properties. Several studies have shown that vitamins play a crucial role in the homoeostasis o...
Principles of a Non-orthogonal Optical Surface with Potential for Correction of Irregular Astigmatism [0.03%]
用于矫正不规则散光的非正交光学曲面的设计原则
David A Atchison,Arthur Ho
David A Atchison
Purpose: Non-orthogonal lenses, in which the principal meridians of the cylinder surfaces are not perpendicular to each other, can be used to improve vision in the condition of irregular astigmatism. A procedure is develo...
Stakeholder Perspectives of Implementation Barriers of Artificial Intelligence in Eye Care: A qualitative framework-based study [0.03%]
利益相关者视角：基于定性框架的眼科人工智能实施障碍研究
Judy Nam,Angelica Ly,Sarita Herse et al.
Judy Nam et al.
Purpose: Despite the revolution of artificial intelligence (AI), its integration remains limited in healthcare. A comprehensive understanding of the barriers to implementation is crucial to enhance the utilisation of AI. ...
Current Evidence on Options and Efficacy of Combination Therapy for Myopia Control-A Narrative Review [0.03%]
控制近视的组合疗法选项及疗效的现有证据-综述性文章
Swapnil Thakur,Tian Han,Mark A Bullimore et al.
Swapnil Thakur et al.
Purpose: Combination therapy for controlling myopia progression has become a topic of interest among both clinicians and researchers because of the rising demand to control rapidly progressing myopia. This review recapitu...
Vestibular Dysfunction and Binocular Vision Impairment: A New Clinical Perspective [0.03%]
前庭功能障碍和双眼视觉损害：新的临床视角
Xixi Yu,E Tian,Jun Wang et al.
Xixi Yu et al.
Background: Individuals with vestibular dysfunction frequently experience dizziness, nausea and imbalance in visually complex or dynamic environments, such as during computer use, shopping, walking in crowds or even durin...
Efficacy of Multifocal Spectacles for Myopia Control in Pre-myopic Children: A Multicentre Real-world Study [0.03%]
多焦点眼镜控制学龄前儿童近视的疗效研究：一项真实世界多中心研究
Jing Rao,Qizhi Zhou,Yongchuan He et al.
Jing Rao et al.
Purpose: To evaluate the efficacy of multifocal (MF) spectacles, compared with single-vision (SV) spectacles, in controlling myopia progression and delaying myopia onset amongst Chinese children with pre-myopia (spherical...
Performance of a Monthly, Reusable, Soft Contact Lens in Participants Who Previously Dropped Out of Contact Lenses [0.03%]
以前放弃佩戴角膜接触镜的受试者佩戴月抛软性角膜接触镜的情况分析
Andrew D Pucker,Gina Wesley,Shane Kannarr et al.
Andrew D Pucker et al.
Purpose: To refit contact lens (CL) dropouts who dropped out of CLs because of dryness or discomfort into lehfilcon A (TOTAL30®) monthly, spherical CLs to determine the frequency that they can be comfortably refitted int...
Negligible Rebound in Myopia Progression Following Cessation of Treatment with 0.01% Atropine for 3 years: Year-4 Results from the CHAMP Phase 3 Clinical Trial [0.03%]
低浓度阿托品治疗3年后停药后近视进展的轻微反跳：CHAMP III期临床试验第4年结果
Karla Zadnik,Erica Schulman,Ian Flitcroft et al.
Karla Zadnik et al.
Introduction: Stage 2 of the Childhood Atropine for Myopia Progression (CHAMP) study was conducted to observe the safety, efficacy and rebound effects of low-dose atropine sulphate ophthalmic solutions (0.01% and 0.02%) f...